Last reviewed · How we verify
NCT05595941
Tele-yoga in the Rehabilitation of Patients With Chronic Post-stroke Sequelae
NA trial testing tele-yoga in Stroke Sequelae in 11 participants. Terminated before completion.
1 April 2023
Quick facts
| Lead sponsor | Hopital La Musse |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 11 |
| Start date | 1 October 2022 |
| Primary completion | 1 April 2023 |
| Estimated completion | 1 September 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- tele-yoga
Conditions studied
- Stroke Sequelae — all drugs for Stroke Sequelae →
Sponsor
Hopital La Musse
Who can join
18 and older, any sex, with Stroke Sequelae. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Stroke is a major health problem and can cause long-term disability. Among these sequelae, there are balance and mobility disorders, but also a higher rate of anxiety or depression disorders. This impairments impact activity of daily living, and social reintegration. That why the investigators need to explore options for long-term sustainable interventions that which takes into account the patient as a whole. In particular, regular physical activity is recommended, but it must be adaptable to the patient's impairments. Teaching yoga may be an interesting option. Indeed, yoga is a mind-body practice which become increasingly widespread in the world. Recent studies highlight positive effect of yoga for this population. However, accessibility to yoga classes can be limited by many factors: lack of transportation, lack of available health professionals, confinement requirements... Therefore, it seems relevant to evaluate the effectiveness of yoga delivered through tele-rehabilitation. The main objective of this study is to evaluate the effectiveness of a tele-yoga program adapted to stroke survivors to improve their functional balance. The secondary objectives are to evaluate the effectiveness of the adapted tele-yoga program in improving functional mobility, anxiety, depression and reintegration into normal life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05595941
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke Sequelae
Currently open trials in the same condition.
- NCT07113067 — Accelerated rTMS vs. Sham for Stroke Apathy · Phase 1, PHASE2 · recruiting
- NCT06797154 — A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Subacute Stroke Survivors · NA · recruiting
- NCT05626894 — Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors · Phase 2 · recruiting
- NCT06289569 — Home Tele Rehabilitation Therapy for Vascular Dementia · NA · recruiting
- NCT06593184 — Efficacy of Trans-spinal Magnetic Stimulation on Functional Mobility in Chronic Stroke Patients · NA · recruiting
Other Hopital La Musse trials
Trials by the same sponsor.
- NCT07495839 — The Impact of Equine-Assisted Therapy on Mental Health and Addictive Behaviors in Patients Receiving Addiction Treatment · NA · not yet recruiting
- NCT07495891 — Sustainability of the Effects of an Adapted Physical Activity Program on Physical Fitness and Psycho-behavioral Factors · NA · not yet recruiting
- NCT07371260 — Effects of Virtual Reality With Multisensory Stimulation on Emotional and Behavioral Disorders in Individuals With Acqui · NA · not yet recruiting
- NCT07129928 — Organizational Strategies and Psychosocial Skills for Maintaining Physical Activity After a Depressive Episode: a 3-mont · not yet recruiting
- NCT06719063 — Effect of Immersive Virtual Reality With Multisensory Stimulation on the Functional Impact of Hemineglect Secondary to a · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05595941 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hopital La Musse
- Last refreshed: 21 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05595941.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing